Pharmena PHR.WA · PLN

Market value

PLN 31.9m

Last close × shares

Volume

369

Shares, 9 Nov 2026

Its shares trade on GPW under the ticker PHR.WA. It has been listed since 25 August 2008. In the fiscal year to 31 December 2025, it reported revenue of PLN 1.6m and a net loss of PLN 2.8m. At that date it held total assets of PLN 10.9m and shareholders' equity of PLN 9.6m.

PHARMENA SA engages in developing and marketing products based on a patented, physiological, and natural active substance 1-MNA. The company is headquartered in Lodz, Woj. Lodzkie. The company went IPO on 2008-08-25. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.

Figures and description from our data supplier, not checked against the company's own report.

More about Pharmena →

We have not reported on Pharmena yet.

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.